Skip to main content
MGTX
NASDAQ Life Sciences

MeiraGTx Repurchases $18.2M in Shares from Perceptive Master Fund, Securing 12-Month Lock-Up

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
8
Price
$7.95
Mkt Cap
$639.903M
52W Low
$4.55
52W High
$9.73
Market data snapshot near publication time

summarizeSummary

MeiraGTx Holdings plc executed an $18.2 million share repurchase from Perceptive Life Sciences Master Fund, a significant capital allocation that also includes a 12-month lock-up on Perceptive's remaining shares.


check_boxKey Events

  • Significant Share Repurchase

    MeiraGTx repurchased 2,300,000 ordinary shares for $18.193 million at $7.91 per share.

  • Major Investor Sale for Tax Optimization

    Perceptive Life Sciences Master Fund, a major institutional investor and >10% owner, sold shares citing year-end portfolio tax optimization activities, rather than fundamental concerns about the company.

  • 12-Month Lock-Up Agreement

    Perceptive and its affiliates agreed to a 12-month lock-up period, restricting the sale or transfer of their remaining substantial shareholdings.

  • Debt Holder Consent Secured

    Perceptive Credit Holdings III, LP, a significant noteholder and affiliate of the selling shareholder, provided consent for the repurchase, waiving any potential default under the existing Notes Purchase Agreement.


auto_awesomeAnalysis

The company's significant share repurchase demonstrates a commitment to enhancing shareholder value by reducing the outstanding share count. The transaction, priced at the volume-weighted average price, involved a major institutional investor, Perceptive Life Sciences Master Fund, which cited year-end tax optimization as the reason for its sale, mitigating concerns about a loss of confidence. Furthermore, Perceptive's agreement to a 12-month lock-up on its remaining substantial holdings signals continued long-term commitment. This move also required and received consent from Perceptive Credit Holdings III, a key debt holder, ensuring the repurchase aligns with existing financial agreements.

At the time of this filing, MGTX was trading at $7.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $639.9M. The 52-week trading range was $4.55 to $9.73. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MGTX - Latest Insights

MGTX
Apr 30, 2026, 8:04 AM EDT
Filing Type: DEF 14A
Importance Score:
8
MGTX
Apr 24, 2026, 4:46 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
MGTX
Apr 24, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
9
MGTX
Apr 16, 2026, 5:25 PM EDT
Filing Type: 424B5
Importance Score:
8
MGTX
Apr 16, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
8
MGTX
Apr 16, 2026, 7:47 AM EDT
Source: GlobeNewswire
Importance Score:
8
MGTX
Apr 16, 2026, 7:16 AM EDT
Filing Type: 8-K
Importance Score:
9
MGTX
Apr 16, 2026, 7:09 AM EDT
Filing Type: 8-K
Importance Score:
9
MGTX
Apr 16, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
MGTX
Mar 30, 2026, 8:15 AM EDT
Source: Wiseek News
Importance Score:
7